On September 2003, BioFire Diagnostics, Inc. was awarded the JBAIDS (Joint Biological Agent Identification and Diagnostic System) contract. The JBAIDS program was created to provide rapid positive identification and diagnostic confirmation of biological warfare agents and other pathogens of operational concern for the four branches of the U.S. Military: U.S. Army, U.S. Navy, U.S. Air Force, and U.S. Marine Corps.
The JBAIDS instrument evolved from the R.A.P.I.D. System for this contract as a reusable, portable, and modifiable system capable of simultaneous, reliable identification of multiple biological warfare agents and pathogens of operational concern and clinical significance.
This instrument is configured to support reliable, quick, and specific identification of biological agents from various clinical specimens and environmental samples. It also enhances force protection by providing medical personnel and commanders an expedient means to reliably and quickly identify naturally occurring or intentional biological threats. BioFire Diagnostics’ R.A.P.I.D.® System (the predecessor to the JBAIDS System) outperformed eight other competitors for the contract.
Today, the JBAIDS program is moving forward at great speed outfitting the US Military with the latest in biological warfare detection systems. This program has allowed BioFire Diagnostics to expand their military and commercial products and services as well as allowed them to build strong relationships throughout the defense community.